Evidence map›Paper›PMID 36542548›Full record

ArticleAnnals of clinical and translational neurology2023

White matter hyperintensity, neurofilament light chain, and cognitive decline.

Anisa Dhana, Charles DeCarli, Klodian Dhana, Pankaja Desai, Robert S Wilson, Denis A Evans, Kumar B Rajan

Abstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anisa DhanaRush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA.ORCID 0000-0001-5073-8669
Charles DeCarliDepartment of Neurology, University of California at Davis, Sacramento, California, USA.
Klodian DhanaRush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA.ORCID 0000-0002-6397-7009
Pankaja DesaiRush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA.
Robert S WilsonRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
Denis A EvansRush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA.
Kumar B RajanRush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA.

Funding

The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)U19NS120384 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Kumar B. Rajan · 2020 to 2026
$61.9M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Rachel A Whitmer · 2021 to 2026
$25.2M
Impact of Neuroinflammation on AD Occurrence: A Bi-Generational Population StudyR01AG073627 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI NEELUM T. AGGARWAL, DENIS A EVANS · 2021 to 2026
$14.0M
Preserving Cognitive Resilience: A Biracial Parent-Offspring Study (18-4674) - Feasibility StudyR01AG058679 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI EVANS, DENIS A, RAJAN, KUMAR B. · 2019 to 2024
$13.8M
Factors Influencing Decline in AD Trends in a Biracial Population StudyRF1AG057532 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RAJAN, KUMAR B. · 2017 to 2017
$1.7M
Nonlinear Models of Cognition Preceding AD in a Biracial Population SampleR01AG051635 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RAJAN, KUMAR B. · 2016 to 2020
$1.5M
Neuroscience of Cognitive AgingT32AG050061 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DECARLI, CHARLES · 2016 to 2020
$869k
NIA NIH HHS P30 AG072972NIA NIH HHS P30AG072972NIA NIH HHS R01 AG051635NIA NIH HHS R01AG058675NIA NIH HHS R01 AG058679NIA NIH HHS R01 AG073627NIA NIH HHS R01AG073627NIA NIH HHS RF1 AG057532NIA NIH HHS RF1AG057532NIA NIH HHS T32 AG050061NINDS NIH HHS U19 NS120384
6 · The paper itself

Abstract

objectiveWe aimed to determine whether combining white matter hyperintensity (WMH) with neurofilament light chain (NfL) could provide additional information for cognition in older adults.

methodsUtilizing data from the population-based Chicago Health and Aging Project, we studied 701 individuals with both biomarkers and cognitive data during the follow-up period. NfL was measured using an ultrasensitive immunoassay, single-molecule array technology. MRI scans of the brain were acquired using 1.5-T systems. Global cognitive function was created as a composite measure of four neuropsychological tests, standardized and averaged to z-scores. Multivariable linear mixed-effects models were used to evaluate the association of WMH and NfL with the rate of cognitive decline.

resultsHigher WMH and NfL were associated with a faster rate of cognitive decline during the follow-up;

interpretationWhile both biomarkers, WMH and NfL, were similarly associated with the annual rate of cognitive decline, our study suggests that they provide different underlying mechanisms affecting cognition.

Indexed as

Cognitive DysfunctionWhite MatterAgedBiomarkersBrainHumansIntermediate FilamentsBiomarkers

Identifiers

PMID36542548
PMCPMC10014007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.